Search PubMed⌕ Search

Biomedical subjects

U Gundert-Remy

Publications and source records attributed to U Gundert-Remy.

110 records · Page 7Linked to original sources

[Cerebrovascular insufficiency and compliance with drug therapy].

Particularly elder multimorbid patients suffering from a cerebrovascular insufficiency need a long term therapy. One condition for success, however, is the regular intake of drugs by the patient. Therefore the final goal is the increase of drug-compliance. This is based on the enhancement of the knowledge of the actual drug-compliance, the subject we wanted to learn more about by empirical investigations. During one year the drug-compliance of each patient of the Special Clinic Klausenbach was tested over a period of 20 days. The results were taken by checking riboflavin fluorometrically (method according to Gundert-Remy). In this way the patients could be classified as "takers" and "non-takers". The following variables wee considered: diagnoses, marital status, age, nationality, profession, IQ, mood, subjective evaluation of success of cure and medication. since according to a pre-study foreigners show a lower rate of compliance we restricted the sample to the 892 german cure patients, 343 of whom suffered from cerebrovascular diseases. Their compliance-level was almost 50%. The results of the subgroups hardly differed. The cure patients suffering from cerebrovascular insufficiencies did not show any striking compliance behaviour: the values are far below the ideal value, however. Further multivariate statistical analyses are designed to contribute to the development of effective measures of intervention.

Aged↗

[Age as a factor in dose-response relationship of drugs].

Drug therapy in the elderly requires careful individualization of the dosage. Whether dose adjustment is due to altered pharmacokinetic or due to altered pharmacodynamic is a matter of experimental evidence which can be found by performing studies with simultaneous measurements of concentration and effect over time. The kinetic of drugs in the elderly can be characterized by an altered volume of distribution, an altered protein binding, an impaired metabolism and renal excretion. There is a wide interindividual variation of the alterations which are further influenced by environmental factors such as smoking and nutrition. In generalization of the results it can be assumed that the concentration of drugs is elevated in the elderly and that the excretion will be prolonged. Hence, it is safe to reduce the dose in the elderly. The influence of age on factors which determine the effect of drugs is much less investigated than the factors influencing the pharmacokinetic. With respect to side-effects, it seems that the elderly population is a population at special risk. However, it is unclear whether this finding is explained on a pharmacodynamic basis (e.g., enhanced receptor sensitivity, impaired homeostatic mechanisms), as analyses are lacking in investigating the relationship between concentration and effect. As there is no evidence besides a special situation with betablockers that aged patients require higher doses than younger ones, it is wise to use doses at the lower range for the treatment of aged patients. In case of new symptom side-effects of drugs should be considered as the underlying cause.

Aged↗